Literature DB >> 11738867

Regulation of transcription and chromatin by methyl-CpG binding protein MBD1.

M Nakao1, S Matsui, S Yamamoto, K Okumura, M Shirakawa, N Fujita.   

Abstract

DNA methylation is important for epigenetic regulation of genome, and it is interpreted by specific protein factors that contain a highly conserved methyl-CpG binding domain (MBD). There are at present five mammalian MBD family proteins: MBD1, MBD2, MBD3, MBD4 and MeCP2. In the family of methyl-CpG binding proteins, MBD1 is characterized by the presence of MBD, two or three cysteine-rich CXXC motifs, and the C-terminal transcriptional repression domain (TRD). In addition, MBD1 has at least five isoforms due to alternative splicing events, resulting in the existence of CXXC1, CXXC2, and CXXC3 in MBD1 isoform v1 (MBD1v1) and MBD1v2, and CXXC1 and CXXC2 in MBD1v3 and MBD1v4. MBD1v1 represses transcription preferentially from both unmethylated and hypomethylated promoters, while MBD1v3 inhibits hypermethylated but not unmethylated promoter activities. The MBD and CXXC3 sequences are responsible for the ability to bind methylated and unmethylated DNAs, respectively. MBD1 is also found to be a chromosomal protein that forms many foci within the nucleus. These findings suggest that MBD1 is a unique transcriptional regulator depending on the density of methyl-CpG pairs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738867     DOI: 10.1016/s0387-7604(01)00348-5

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  11 in total

1.  The methyl-CpG binding protein MBD1 interacts with the p150 subunit of chromatin assembly factor 1.

Authors:  Brian E Reese; Kurtis E Bachman; Stephen B Baylin; Michael R Rountree
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

2.  p53 chromatin epigenetic domain organization and p53 transcription.

Authors:  Chia-Hsin Su; Yih-Jyh Shann; Ming-Ta Hsu
Journal:  Mol Cell Biol       Date:  2008-10-20       Impact factor: 4.272

Review 3.  Understanding paternal genome demethylation through live-cell imaging and siRNA.

Authors:  Kazuo Yamagata; Yuki Okada
Journal:  Cell Mol Life Sci       Date:  2011-01-15       Impact factor: 9.261

4.  The Roles of the Methyl-CpG Binding Proteins in Cancer.

Authors:  Lee Parry; Alan R Clarke
Journal:  Genes Cancer       Date:  2011-06

5.  Role of TET2 mutations in myeloproliferative neoplasms.

Authors:  Elodie Pronier; François Delhommeau
Journal:  Curr Hematol Malig Rep       Date:  2012-03       Impact factor: 3.952

6.  Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression.

Authors:  Kalpana Ghoshal; Sarmila Majumder; Jharna Datta; Tasneem Motiwala; Shoumei Bai; Sudarshana M Sharma; Wendy Frankel; Samson T Jacob
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

Review 7.  An epigenetic regulator: methyl-CpG-binding domain protein 1 (MBD1).

Authors:  Lu Li; Bi-Feng Chen; Wai-Yee Chan
Journal:  Int J Mol Sci       Date:  2015-03-05       Impact factor: 5.923

Review 8.  DNA Methylation Dynamics and Cocaine in the Brain: Progress and Prospects.

Authors:  Kathryn Vaillancourt; Carl Ernst; Deborah Mash; Gustavo Turecki
Journal:  Genes (Basel)       Date:  2017-05-12       Impact factor: 4.096

Review 9.  Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression.

Authors:  Edward A Ratovitski
Journal:  Curr Genomics       Date:  2017-04       Impact factor: 2.236

10.  Transcriptional repressor domain of MBD1 is intrinsically disordered and interacts with its binding partners in a selective manner.

Authors:  Umar Farook Shahul Hameed; Jackwee Lim; Qian Zhang; Mariusz A Wasik; Daiwen Yang; Kunchithapadam Swaminathan
Journal:  Sci Rep       Date:  2014-05-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.